Cas No.: 1253739-14-8
PRODUCT INFORMATION
Description
CGGK (Cys-Gly-Gly-Lys) serves as a benchmark control peptide in studies evaluating CAQK (Cys-Ala-Gln-Lys). CAQK is a cysteine-containing tetrapeptide studied for its sulfur-mediated conjugation capabilities and potential research applications. As a structurally analogous sequence, CGGK enables comparative functional validation by helping to identify and eliminate non-specific interactions in experimental models, ensuring observed effects are sequence-specific.
Molecular Weight
363.43
Purity
> 95%
Formula
C₁₃H₂₅N₅O₅S
Product Type
Targeting Peptide
Sequence
Cys-Gly-Gly-Lys
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- HER2-targeted Peptide H6F (CAT#: OLY-1025-YS-5)
- Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Targeting Peptide (CAT#: OLY-1025-YS-51)
- M2 Targeting Peptide (CAT#: OLY-1025-YS-40)
- Cys-PKHB1 Targeting Peptide (CAT#: OLY-1025-YS-33)
- WLSEAGPVVTVRALRGTGSW TFA Targeting Peptide (CAT#: OLY-1025-YS-67)
- IETP2 Targeting Peptide (CAT#: OLY-1025-YS-30)
- Cyclo(-RGDfK) TFA Targeting Peptide (CAT#: OLY-1025-YS-53)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.